Specifically, GLUD1 is overexpressed in certain malignancies, such as non-small cell lung cancer (NSCLC) [90]; while it is downregulated in hepatocellular carcinoma (HCC) and clear cell renal carcinoma [91]. The gene discussed is GLUD1; the disease is hepatocellular carcinoma.